{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:11:41Z","timestamp":1779275501552,"version":"3.51.4"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>\n                    Rheumatoid arthritis (RA) is a chronic, progressive inflammatory systemic autoimmune disease with incompletely understood etiology, causing substantial global disease burden. This study aimed to identify plasma proteins associated with RA using Mendelian randomization (MR) of large-scale plasma proteomics, providing potential biomarkers and therapeutic targets for early diagnosis and personalized treatment. We conducted a large-scale plasma proteome MR study using genetic data from 58,293 Europeans (14,361 RA patients and 43,932 controls) in a genome-wide association study. Plasma protein quantitative trait loci data for 4907 adaptors in 35,559 Icelanders were obtained from Ferkingstad et al. (2021). MR methods included MR-Egger, weighted median, inverse-variance weighting, Wald ratio, simple, and weighted models. Heterogeneity was assessed with Cochran\n                    <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                    test; horizontal pleiotropy was evaluated using the MR-Egger intercept and MR-PRESSO global test. Sensitivity was assessed by leave-one-out analysis. Analyses of gene ontology (describing biological functions), Kyoto Encyclopedia of Genes and Genomes (mapping functional pathways), and protein\u2013protein interaction (identifying molecular interaction networks) were also performed. MR identified associations between 4907 plasma proteins and RA. Using an exploratory false discovery rate\u2005&lt;\u20050.20, 11 novel plasma proteins were significantly associated. For example, genetically higher C2 levels increased RA risk (odds ratio per 1-standard deviation\u2005=\u20051.38; 95% confidence interval: 1.21\u20131.58), whereas higher USP25 decreased risk (odds ratio per 1-standard deviation\u2005=\u20050.61; 95% confidence interval: 0.48\u20130.79). C2, HS3ST3A1, MAPK3, PRSS57, and TNFAIP8 are potential risk factors; AIF1, ATF6, CXCL16, HMBS, DNASE1L2, and USP25 are protective. Inverse MR confirmed ATF6\u2019s negative correlation with RA risk. Gene ontology analysis indicated involvement in monocyte migration, leukocyte chemotaxis, and cytotaxis. Kyoto Encyclopedia of Genes an Genomes analysis revealed enrichment in pertussis, IL-17, and chemokine signaling pathways. Protein\u2013protein interaction analysis by GeneMANIA identified 20 additional interacting genes and 416 links. This study highlights novel plasma proteins and pathways causally linked to RA, warranting functional and clinical follow-up to clarify biological roles and translational potential.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045647","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:02:13Z","timestamp":1763571733000},"page":"e45647","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Plasma proteins and rheumatoid arthritis: A Mendelian randomization analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Chuan","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Xiao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[{"name":"Hospital Office, Red Cross Hospital of Yulin City, Yulin, Guangxi Zhuang Autonomous Region, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Continuing Education, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-591X","authenticated-orcid":false,"given":"Jianwen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.mcna.2020.10.006","article-title":"Rheumatoid arthritis: early diagnosis and treatment.","volume":"105","author":"Cush","year":"2021","journal-title":"Med Clin North Am"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ng.479","article-title":"Genetic variants at CD28, PRDM1 and CD2\/CD58 are associated with rheumatoid arthritis risk.","volume":"41","author":"Raychaudhuri","year":"2009","journal-title":"Nat Genet"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/jama.2022.0786","article-title":"What is rheumatoid arthritis?","volume":"327","author":"Smith","year":"2022","journal-title":"JAMA"},{"key":"R4-20260520","first-page":"455","article-title":"Rheumatoid arthritis: common questions about diagnosis and management.","volume":"97","author":"Wasserman","year":"2018","journal-title":"Am Fam Physician"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview.","volume":"10","author":"Radu","year":"2021","journal-title":"Cells"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/annrheumdis-2021-220973","article-title":"EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis.","volume":"81","author":"Nagy","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome.","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"e73873","DOI":"10.7554\/eLife.73873","article-title":"Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.","volume":"10","author":"Huang","year":"2021","journal-title":"Elife"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1186\/s12859-022-04706-x","article-title":"An optimal variant to gene distance window derived from an empirical definition of cis and trans protein QTLs.","volume":"23","author":"Fauman","year":"2022","journal-title":"BMC Bioinf"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"7680","DOI":"10.1038\/s41467-023-43485-8","article-title":"Evaluation of circulating plasma proteins in breast cancer using Mendelian randomization.","volume":"14","author":"M\u00e4larstig","year":"2023","journal-title":"Nat Commun"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development.","volume":"9","author":"Finan","year":"2017","journal-title":"Sci Transl Med"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease.","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat Genet"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/STROKEAHA.120.032617","article-title":"Mendelian randomization studies in stroke: exploration of risk factors and drug targets with human genetic data.","volume":"52","author":"Georgakis","year":"2021","journal-title":"Stroke"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1093\/brain\/awac193","article-title":"A Mendelian randomization study investigating the causal role of inflammation on Parkinson\u2019s disease.","volume":"145","author":"Bottigliengo","year":"2022","journal-title":"Brain"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data [published correction appears in PLoS Genet. 2017 Dec 29;13(12):e1007149. doi: 10.1371\/journal.pgen.1007149].","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ije\/dyaa241","article-title":"Systemic inflammatory regulators and risk of Alzheimer\u2019s disease: a bidirectional Mendelian-randomization study.","volume":"50","author":"Yeung","year":"2021","journal-title":"Int J Epidemiol"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta\u2010analysis and Mendelian randomization: a review.","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"1363200","DOI":"10.3389\/fcvm.2024.1363200","article-title":"Exploring the causal relationship between immune cell and all-cause heart failure: a Mendelian randomization study.","volume":"11","author":"Li","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R22-20260520","first-page":"1961","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.","volume":"45","author":"Bowden","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"1367106","DOI":"10.3389\/fnagi.2024.1367106","article-title":"Two-sample Mendelian randomization analysis of 91 circulating inflammatory protein levels and amyotrophic lateral sclerosis.","volume":"16","author":"Xiao","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"W60","DOI":"10.1093\/nar\/gky311","article-title":"GeneMANIA update 2018.","volume":"46","author":"Franz","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.4049\/jimmunol.1301293","article-title":"NSP4 is stored in azurophil granules and released by activated neutrophils as active endoprotease with restricted specificity.","volume":"191","author":"Perera","year":"2013","journal-title":"J Immunol"},{"key":"R29-20260520","doi-asserted-by":"crossref","first-page":"e0132818","DOI":"10.1371\/journal.pone.0132818","article-title":"Design of a selective substrate and activity based probe for human neutrophil serine protease 4.","volume":"10","author":"Kasperkiewicz","year":"2015","journal-title":"PLoS One"},{"key":"R30-20260520","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1002\/jcb.29643","article-title":"Protective effect of microRNA-134-3p on multiple sclerosis through inhibiting PRSS57 and promotion of CD34+ cell proliferation in rats.","volume":"121","author":"Song","year":"2020","journal-title":"J Cell Biochem"},{"key":"R31-20260520","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.molimm.2019.05.012","article-title":"Complement and its environmental determinants in the progression of human rheumatoid arthritis.","volume":"112","author":"Bemis","year":"2019","journal-title":"Mol Immunol"},{"key":"R32-20260520","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.1975.tb36039.x","article-title":"Activation of the complement and properdin systems in rheumatoid arthritis.","volume":"256","author":"Ruddy","year":"1975","journal-title":"Ann N Y Acad Sci"},{"key":"R33-20260520","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780340905","article-title":"Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids.","volume":"34","author":"Firestein","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R34-20260520","doi-asserted-by":"crossref","first-page":"12547","DOI":"10.1074\/jbc.RA119.007735","article-title":"The protein tyrosine phosphatase ptpn7 is a negative regulator of erk activation and thromboxane generation in platelets.","volume":"294","author":"Inamdar","year":"2019","journal-title":"J Biol Chem"},{"key":"R35-20260520","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"R36-20260520","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2010.143529","article-title":"Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR\/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets.","volume":"71","author":"de Launay","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R37-20260520","doi-asserted-by":"crossref","first-page":"118026","DOI":"10.1016\/j.jep.2024.118026","article-title":"Effects of Viscum coloratum (Kom.) Nakai on collagen-induced rheumatoid arthritis.","volume":"327","author":"Wang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"R38-20260520","doi-asserted-by":"crossref","first-page":"967164","DOI":"10.3389\/fphar.2022.967164","article-title":"Therapeutic effects of shaogan fuzi decoction in rheumatoid arthritis: Network pharmacology and experimental validation.","volume":"13","author":"Shi","year":"2022","journal-title":"Front Pharmacol"},{"key":"R39-20260520","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1039\/D3MO00029J","article-title":"A Q-marker screening strategy based on ADME studies and systems biology for Chinese herbal medicine, taking Qianghuo Shengshi decoction in treating rheumatoid arthritis as an example.","volume":"19","author":"Wang","year":"2023","journal-title":"Mol Omics"},{"key":"R40-20260520","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1358\/DNP.2008.21.5.1219006","article-title":"Erk inhibitors as a potential new therapy for rheumatoid arthritis.","volume":"21","author":"Ohori","year":"2008","journal-title":"Drug News Perspect"},{"key":"R41-20260520","doi-asserted-by":"crossref","first-page":"e001274","DOI":"10.1161\/JAHA.114.001274","article-title":"Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.","volume":"3","author":"Mooij","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R42-20260520","doi-asserted-by":"crossref","first-page":"6724295","DOI":"10.1155\/2022\/6724295","article-title":"HS3ST3A1 and CAPN8 serve as immune-related biomarkers for predicting the prognosis in thyroid cancer.","volume":"2022","author":"Chen","year":"2022","journal-title":"J Oncol"},{"key":"R43-20260520","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrg840","article-title":"Organogenesis: molecular mechanisms of tubulogenesis.","volume":"3","author":"Hogan","year":"2002","journal-title":"Nat Rev Genet"},{"key":"R44-20260520","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1002\/art.34664","article-title":"Tumor necrosis factor alpha-induced proteins: natural brakes on inflammation.","volume":"64","author":"Jacques","year":"2012","journal-title":"Arthritis Rheum-Us"},{"key":"R45-20260520","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.20037","article-title":"Novel tumor necrosis factor alpha\u2011regulated genes in rheumatoid arthritis.","volume":"50","author":"Zhang","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R46-20260520","first-page":"993","article-title":"The pro-apoptotic effects of TIPE2 on AA rat fibroblast-like synoviocytes via regulation of the DR5-caspase-NF-\u03baB pathway in vitro.","volume":"9","author":"Shi","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R47-20260520","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/cbin.10861","article-title":"Tacrolimus regulates endoplasmic reticulum stress-mediated osteoclastogenesis and inflammation: In vitro and collagen-induced arthritis mouse model.","volume":"42","author":"Lee","year":"2018","journal-title":"Cell Biol Int"},{"key":"R48-20260520","doi-asserted-by":"crossref","first-page":"1438803","DOI":"10.3389\/fimmu.2024.1438803","article-title":"Ferroptosis and endoplasmic reticulum stress in rheumatoid arthritis.","volume":"15","author":"Ao","year":"2024","journal-title":"Front Immunol"},{"key":"R49-20260520","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/ijms23020905","article-title":"Rheumatoid arthritis: pathogenic roles of diverse immune cells.","volume":"23","author":"Jang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R50-20260520","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbagrm.2018.08.001","article-title":"LPS promotes HBO1 stability via USP25 to modulate inflammatory gene transcription in THP-1 cells.","volume":"1861","author":"Long","year":"2018","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"R51-20260520","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fimmu.2017.00399","article-title":"NF-\u03baB pathway in autoinflammatory diseases: Dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases.","volume":"8","author":"Aksentijevich","year":"2017","journal-title":"Front Immunol"},{"key":"R52-20260520","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3892\/mmr.2022.12863","article-title":"Downregulation of deubiquitinating enzyme USP25 promotes the development of allergic rhinitis by enhancing TSLP signaling in the nasal epithelium.","volume":"26","author":"Chang","year":"2022","journal-title":"Mol Med Rep"},{"key":"R53-20260520","doi-asserted-by":"crossref","first-page":"7536805","DOI":"10.1155\/2019\/7536805","article-title":"Oxidative stress in rheumatoid arthritis: what the future might hold regarding novel biomarkers and add-on therapies.","volume":"2019","author":"da Fonseca","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"R54-20260520","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrrheum.2017.49","article-title":"Immunometabolism in early and late stages of rheumatoid arthritis.","volume":"13","author":"Weyand","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"R55-20260520","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s10067-014-2741-9","article-title":"Elevated levels of serum sCXCL16 in systemic lupus erythematosus; potential involvement in cutaneous and renal manifestations.","volume":"33","author":"Qin","year":"2014","journal-title":"Clin Rheumatol"},{"key":"R56-20260520","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbrc.2012.10.122","article-title":"RANKL downregulates cell surface CXCR6 expression through JAK2\/STAT3 signaling pathway during osteoclastogenesis.","volume":"429","author":"Li","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R57-20260520","doi-asserted-by":"crossref","first-page":"155502","DOI":"10.1016\/j.cyto.2021.155502","article-title":"Cyanidin attenuates IL-17A cytokine signaling mediated monocyte migration and differentiation into mature osteoclasts in rheumatoid arthritis.","volume":"142","author":"Samarpita","year":"2021","journal-title":"Cytokine"},{"key":"R58-20260520","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/ar2457","article-title":"The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.","volume":"10","author":"Brown","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R59-20260520","doi-asserted-by":"crossref","first-page":"601618","DOI":"10.3389\/fmed.2020.601618","article-title":"Osteoporosis in rheumatoid arthritis: dangerous liaisons.","volume":"7","author":"Llorente","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"R60-20260520","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00281-017-0619-z","article-title":"Selected cytokine pathways in rheumatoid arthritis.","volume":"39","author":"Noack","year":"2017","journal-title":"Semin Immunopathol"},{"key":"R61-20260520","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/tox.23802","article-title":"HDAC2 exacerbates rheumatoid arthritis progression via the IL-17-CCL7 signaling pathway.","volume":"38","author":"Mao","year":"2023","journal-title":"Environ Toxicol"},{"key":"R62-20260520","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.2147\/DDDT.S423022","article-title":"Integrated network pharmacology and experimental approach to investigate the protective effect of jin gu lian capsule on rheumatoid arthritis by inhibiting inflammation via IL-17\/NF-\u03baB pathway.","volume":"17","author":"Chen","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"R63-20260520","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/cei.13527","article-title":"Increased expression of CXCL2 in ACPA-positive rheumatoid arthritis and its role in osteoclastogenesis.","volume":"203","author":"Wang","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"R64-20260520","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3349\/ymj.2015.56.4.1134","article-title":"Chemokine signaling pathway involved in CCL2 expression in patients with rheumatoid arthritis.","volume":"56","author":"Zhang","year":"2015","journal-title":"Yonsei Med J"},{"key":"R65-20260520","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00011-015-0905-y","article-title":"CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2\/STAT3 and p38\/MAPK signaling pathway.","volume":"65","author":"Li","year":"2016","journal-title":"Inflamm Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:01:53Z","timestamp":1779274913000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":65,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045647","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-07-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}